Research ExplorerPublicationsLong-term follow-up of gastric MALT lymphoma after H. pylori...

Long-term follow-up of gastric MALT lymphoma after H. pylori eradication

Standard

Long-term follow-up of gastric MALT lymphoma after H. pylori eradication. / Morgner, A; Thiede, C; Bayerdörffer, E; Alpen, B; Wündisch, T; Neubauer, A; Stolte, M.

In: Curr Gastroenterol Rep, Vol. 3, No. 6, 12.2001, p. 516-22.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Morgner, A, Thiede, C, Bayerdörffer, E, Alpen, B, Wündisch, T, Neubauer, A & Stolte, M 2001, 'Long-term follow-up of gastric MALT lymphoma after H. pylori eradication', Curr Gastroenterol Rep, vol. 3, no. 6, pp. 516-22.

APA

Morgner, A., Thiede, C., Bayerdörffer, E., Alpen, B., Wündisch, T., Neubauer, A., & Stolte, M. (2001). Long-term follow-up of gastric MALT lymphoma after H. pylori eradication. Curr Gastroenterol Rep, 3(6), 516-22.

Vancouver

Morgner A, Thiede C, Bayerdörffer E, Alpen B, Wündisch T, Neubauer A et al. Long-term follow-up of gastric MALT lymphoma after H. pylori eradication. Curr Gastroenterol Rep. 2001 Dec;3(6):516-22.

Bibtex

@article{87e1b17587cf4ff6ae10327e95b11a4f,
title = "Long-term follow-up of gastric MALT lymphoma after H. pylori eradication",
abstract = "For almost 10 years, we have been familiar with the concept of mucosa-associated lymphoid tissue (MALT)-type lymphoma of the stomach caused by chronic Helicobacter pylori infection. Many epidemiologic, biologic, and molecular genetic studies have implicated H. pylori for its role in lymphoma genesis. Since the first reports on complete remission of gastric MALT lymphomas after cure of bacterial infection, many clinical studies have investigated the effect of eradicating H. pylori on the course of MALT lymphoma, and indeed were able to confirm remission of the lymphoma. To date, more than 650 patients worldwide have been treated for gastric MALT lymphoma with antibiotics, and we have gained many new insights concerning the biologic behavior of this disease, especially from the deepened knowledge of cytogenetics. Furthermore, factors relevant for the prediction of treatment outcome have been identified, which has helped to stratify patients into risk groups.",
keywords = "Follow-Up Studies, Helicobacter Infections, Helicobacter pylori, Humans, Lymphoma, B-Cell, Marginal Zone, Stomach Neoplasms, Journal Article, Research Support, Non-U.S. Gov't, Review",
author = "A Morgner and C Thiede and E Bayerd{\"o}rffer and B Alpen and T W{\"u}ndisch and A Neubauer and M Stolte",
year = "2001",
month = dec,
language = "English",
volume = "3",
pages = "516--22",
journal = "Curr Gastroenterol Rep",
issn = "1522-8037",
publisher = "Current Medicine Group",
number = "6",

}

RIS

TY - JOUR

T1 - Long-term follow-up of gastric MALT lymphoma after H. pylori eradication

AU - Morgner, A

AU - Thiede, C

AU - Bayerdörffer, E

AU - Alpen, B

AU - Wündisch, T

AU - Neubauer, A

AU - Stolte, M

PY - 2001/12

Y1 - 2001/12

N2 - For almost 10 years, we have been familiar with the concept of mucosa-associated lymphoid tissue (MALT)-type lymphoma of the stomach caused by chronic Helicobacter pylori infection. Many epidemiologic, biologic, and molecular genetic studies have implicated H. pylori for its role in lymphoma genesis. Since the first reports on complete remission of gastric MALT lymphomas after cure of bacterial infection, many clinical studies have investigated the effect of eradicating H. pylori on the course of MALT lymphoma, and indeed were able to confirm remission of the lymphoma. To date, more than 650 patients worldwide have been treated for gastric MALT lymphoma with antibiotics, and we have gained many new insights concerning the biologic behavior of this disease, especially from the deepened knowledge of cytogenetics. Furthermore, factors relevant for the prediction of treatment outcome have been identified, which has helped to stratify patients into risk groups.

AB - For almost 10 years, we have been familiar with the concept of mucosa-associated lymphoid tissue (MALT)-type lymphoma of the stomach caused by chronic Helicobacter pylori infection. Many epidemiologic, biologic, and molecular genetic studies have implicated H. pylori for its role in lymphoma genesis. Since the first reports on complete remission of gastric MALT lymphomas after cure of bacterial infection, many clinical studies have investigated the effect of eradicating H. pylori on the course of MALT lymphoma, and indeed were able to confirm remission of the lymphoma. To date, more than 650 patients worldwide have been treated for gastric MALT lymphoma with antibiotics, and we have gained many new insights concerning the biologic behavior of this disease, especially from the deepened knowledge of cytogenetics. Furthermore, factors relevant for the prediction of treatment outcome have been identified, which has helped to stratify patients into risk groups.

KW - Follow-Up Studies

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Humans

KW - Lymphoma, B-Cell, Marginal Zone

KW - Stomach Neoplasms

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

KW - Review

M3 - SCORING: Journal article

C2 - 11696290

VL - 3

SP - 516

EP - 522

JO - Curr Gastroenterol Rep

JF - Curr Gastroenterol Rep

SN - 1522-8037

IS - 6

ER -